Pain Predict Genetics
Condition(s) studied
Study summary
Pain is the most frequent cause of suffering and disability in society. Despite considerable involvement of genetic factors in pain sensation and sensitivity, the individual genes involved remain largely unidentified.
In this project the investigators will follow patients undergoing elective major surgery for the development of acute and chronic pain. The investigators will search for clinical as well as genetic factors that can predict the development of pain. These can serve as biomarkers to predict acute and chronic pain development and progression in individual patients and help early individual treatment adaptation.
Eligibility
Primary outcome measure(s)
- Genetic risk factors for the development of acute pain using a visual analogue scale. — 7 days
All patients will be followed for 1 year after elective surgery, during this period the investigators will collect acute pain measures using a visual analogue scale (ranging from 0 (no pain) -10 (pain)) before the operation and 1, 2, 3 and 7 days after the operation. - Genetic risk factors for the development of chronic pain (defined as pain (yes or no) for more than 3 months in one specific body area). — 6 months
All patients will be followed for 1 year after elective surgery, during this period the investigators will collect chronic pain measures using a questionnaire before the operation and 1 week, 3 months and 6 months. Chronic pain is defined as pain at a specific body side (yes/no) for more than 3 months.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Radboudumc | Nijmegen | Netherlands |
More Radboud University Medical Center trials in the Netherlands
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT02383342 on ClinicalTrials.gov ↗ ← All trials in the Netherlands